Price T Rowe Associates Inc Epizyme, Inc. Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.42 - $1.48 $5,404 - $19,046
-12,869 Reduced 9.12%
128,228 $188,000
Q1 2022

May 16, 2022
BUY
$1.06 - $2.68 $88,869 - $224,688
83,839 Added 146.42%
141,097 $162,000
Q4 2021

Feb 14, 2022
SELL
$2.5 - $5.19 $92,250 - $191,511
-36,900 Reduced 39.19%
57,258 $143,000
Q3 2021

Nov 15, 2021
SELL
$4.82 - $8.46 $772,202 - $1.36 Million
-160,208 Reduced 62.98%
94,158 $482,000
Q2 2021

Aug 16, 2021
SELL
$6.81 - $9.71 $4.67 Million - $6.66 Million
-685,865 Reduced 72.95%
254,366 $2.11 Million
Q1 2021

May 17, 2021
SELL
$7.45 - $12.32 $4.49 Million - $7.42 Million
-602,356 Reduced 39.05%
940,231 $8.19 Million
Q4 2020

Feb 16, 2021
BUY
$10.34 - $13.77 $16 Million - $21.2 Million
1,542,587 New
1,542,587 $16.8 Million

About Epizyme, Inc.

EPZM Quotes by TradingView
  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email